Expression of breast cancer stem cell markers as predictors of prognosis and response to trastuzumab in HER2-positive breast cancer

BACKGROUND: Breast cancer stem cells (BCSCs) have been suggested to have clinical implications for cancer therapeutics because of their proposed role in chemoresistance. The aim of this study was to investigate the impact of BCSC marker expression on clinical outcome and trastuzumab response in huma...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Br J Cancer
Main Authors: Seo, An Na, Lee, Hee Jin, Kim, Eun Joo, Jang, Min Hye, Kim, Yu Jung, Kim, Jee Hyun, Kim, Sung-Won, Ryu, Han Suk, Park, In Ae, Im, Seock-Ah, Gong, Gyungyub, Jung, Kyung Hae, Kim, Hee Jeong, Park, So Yeon
Formato: Artigo
Idioma:Inglês
Publicado: Nature Publishing Group 2016
Assuntos:
Translational Therapeutics
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4865964/
https://ncbi.nlm.nih.gov/pubmed/27115469
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2016.101
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares